ALBANY -- Almost halfway through a $600 million state program supporting stem cell research, eight medical schools around New York are reporting progress on projects such as replicating liver cells and eradicating leukemia cells.
A new report from Associated Medical Schools of New York updates work at the institutions where hundreds of researchers are starting to unravel causes and potential treatments for conditions ranging from autism to heart disease and cancer. Stem cells are self-renewing and have the ability to develop into other types of cells.
The Mount Sinai School of Medicine reported finding a method to transform human skin cells into stem cells and turned differentiated human stem cells into heart cells. Those findings are expected to result in better understanding of how heart disease develops and allow initial testing of new treatments on stem cells before they are used on human subjects.
The Empire State Stem Cell Program was intended to fund projects in early stages, including those that initially have been unable to get federal or private funding. Grants have also been used for capital projects like renovating labs and establishing new stem cell centers.
The Albert Einstein College of Medicine reported replicating liver cells that could help reduce the need for liver transplants using live donors and cadavers.
Dr. Allan Spiegel said 12 new researchers have been hired with state funding at the Bronx school, which also lists anemia, brain disorders, heart disease and obesity among its stem cell research subjects.
The 11-year program has awarded nearly $223 million in research grants since 2008, with medical schools awarded $137.5 million. This year's state budget includes $44.8 million, the same as last year and down from the $50 million originally planned.
According to the report, the funding has supported about 400 research and related positions from New York City to Buffalo and Rochester.
"This research has the potential to have significant impact on the treatment of patients with specific types of leukemia and will be useful in treating lymphoma and multiple myeloma," the report said.
Read more here:
N.Y. medical schools chart progress with stem cells